Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1;106(6):1737-1739.
doi: 10.3324/haematol.2020.269209.

No association between ECSIT germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma

Affiliations

No association between ECSIT germline mutations and hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma

Shin Yeu Ong et al. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
ECSIT-T419C is a germline mutation not associated with hemophagocytic lymphohistiocytosis in natural killer/T-cell lymphoma patients. (A) Sanger sequencing electropherogram profile for tumor-normal paired samples with heterozygous ECSIT-V140A mutation, identified as L12, L14, L20, L21, and L24 in Jiang et al. (B and C) Representative Sanger sequencing electropherogram profile for two tumor- peripheral blood (B) and buccal swab (C) samples for the ECSITV140A mutation from Singapore local hospitals and the Sun Yat-Sen University Cancer Center in Guangzhou, China. (D) Integrative Genomics Viewer (IGV) snapshot centered around heterozygous germline ECSIT-T419C mutation of the paired tumor-normal exome sequencing data of sample NKT1 from Wen et al. Variant allele frequencies (VAF) were calculated from the number of variant-supporting/total read-counts at ECSIT-T419C. Aligned reads were colored pink according to the read-strand that they were aligned with onto the human reference genome. (E) No association between ECSIT mutation and clinical characteristics of natural killer/T-cell lymphoma patients in Singapore and Taiwan. ECSIT: evolutionarily conserved signaling intermediate in Toll pathway; IPI: international prognostic index, ECOG: Eastern Cooperative Oncology Group, HLH: hemophagocytic lymphohistiocytosis, Mut: mutant; WT: wild-type.

References

    1. Jin Z, Wang Y, Wang J, et al. . Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis. Hematology. 2018;23(4):228-234. - PubMed
    1. Wen H, Ma H, Cai Q, et al. . Recurrent ECSIT mutation encoding V140A triggers hyperinflammation and promotes hemophagocytic syndrome in extranodal NK/T cell lymphoma. Nat Med. 2018; 24(2):154-164. - PubMed
    1. Jiang L, Gu ZH, Yan ZX, et al. . Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma. Nat Genet. 2015;47(9):1061-1066. - PubMed
    1. Kim S, Scheffler K, Halpern AL, et al. . Strelka2: fast and accurate calling of germline and somatic variants. Nat Methods. 2018;15(8):591-594. - PubMed
    1. Henter JI, Horne A, Arico M, et al. . HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124-131. - PubMed

Publication types

MeSH terms

Substances